Tolterodine Tartrate
Who holds supplier records for Tolterodine Tartrate? 17 organisations hold a current record for Tolterodine Tartrate: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (11), Malta (1), Italy (1), Peru (1) and 1 other country (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Tolterodine Tartrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/tolterodine-tartrate
Reading the evidence
- 17 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
11 of the 15 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 14 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (17)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Tolterodine Tartrate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 19649 · latest filing Jul 2006
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 22381 · latest filing Jan 2009
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 23843 · latest filing May 2010
- Maithri Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 34719 · latest filing Mar 2020
- Alkem Laboratories LimitedIndia Company GMP cert on recordActive DMF 30994 · latest filing Sept 2016
- Amino Chemicals LtdMalta Company GMP cert on recordActive DMF 20093 · latest filing Dec 2006
- Cipla LimitedIndia Company GMP cert on recordActive DMF 17018 · latest filing Dec 2003
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 17736 · latest filing Oct 2004
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 29011 · latest filing Mar 2015
- ERREGIERRE SPAItaly Company GMP cert on recordActive DMF 20483 · latest filing Apr 2007
- HOLIDAY LABS MEXICO SA DE CVActive DMF 20096 · latest filing Dec 2006
- INTERQUIM SAPeruCEP Company GMP cert on recordActive DMF 19625, 19599 · latest filing Jul 2006
- Orchid Pharma LimitedIndia Company GMP cert on recordActive DMF 23629 · latest filing Mar 2010
- TAPI NL BVNetherlandsActive DMF 16995 · latest filing Dec 2003
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 25155 · latest filing Sept 2011
- IndiaCEP Company GMP cert on record
- PHARMACEUTICAL WORKS POLPHARMA SACEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (7)
Certificates of Suitability on the EDQM register for Tolterodine Tartrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2020-032 - Rev 02 Tolterodine tartrate | Apr 2026 | — |
| FLEMING LABORATORIES LIMITED Hyderabad | IN | CEP 2022-455 - Rev 00 Tolterodine tartrate | Jul 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2015-020 - Rev 01 Tolterodine tartrate | Dec 2023 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | R1-CEP 2017-007 - Rev 00 Tolterodine tartrate | May 2023 | — |
| MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village | IN | R0-CEP 2021-020 - Rev 01 Tolterodine tartrate | Feb 2023 | — |
| Interquim, S.A. Sant Cugat Del Vallès | ES | R1-CEP 2015-301 - Rev 01 Tolterodine tartrate | Jul 2022 | — |
| PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard Gdanski | PL | R1-CEP 2015-192 - Rev 00 Tolterodine tartrate | Aug 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (7)
Organisations whose Type II DMFs for Tolterodine Tartrate are no longer active. These show a past filing, not current supply.
Show all 7 historical records
- Poland · Inactive DMF 24345 · filed Nov 2010
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 22996 · filed Jul 2009
- Slovenia · Inactive DMF 21184 · filed Dec 2007
- India · Inactive DMF 21164 · filed Dec 2007
- Brazil · Inactive DMF 19510 · filed Jun 2006
- India · Inactive DMF 19324 · filed Mar 2006
- India · Inactive DMF 17026 · filed Dec 2003
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Tolterodine tartrate is used to treat overactive bladder with symptoms of urinary incontinence, urgency, and frequency. It works by relaxing the muscles in the bladder, thereby decreasing urge incontinence.
Chemical identity
- IUPAC name
- (2R,3R)-2,3-dihydroxybutanedioic acid;2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
- Canonical SMILES
- CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
- InChIKey
- TWHNMSJGYKMTRB-KXYUELECSA-N
- Synonyms
- Detrol API, detrol, detrusitol, pnu-200583e, tolterodine l-tartrate
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cholinergic Muscarinic Antagonist
- Mechanism of action
- Cholinergic Muscarinic Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Tolterodine Tartrate?
17 organisations hold an active US FDA Type II Drug Master File or a CEP for Tolterodine Tartrate: APITORIA PHARMA PRIVATE LTD (India), Hetero Drugs Limited (India), Macleods Pharmaceuticals Ltd. (India), Maithri Laboratories Private Limited (India), Alkem Laboratories Limited (India), Amino Chemicals Ltd (Malta), Cipla Limited (India) and Dr. Reddy's Laboratories Ltd. (India), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Tolterodine Tartrate Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 19649), Hetero Drugs Limited (DMF 22381), Macleods Pharmaceuticals Ltd. (DMF 23843), Maithri Laboratories Private Limited (DMF 34719), Alkem Laboratories Limited (DMF 30994), Amino Chemicals Ltd (DMF 20093), Cipla Limited (DMF 17018) and Dr. Reddy's Laboratories Ltd. (DMF 17736) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Tolterodine Tartrate records mean?
7 organisations have only inactive Type II DMFs for Tolterodine Tartrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Tolterodine Tartrate have a European Certificate of Suitability?
Yes. 7 organisations hold a valid CEP for Tolterodine Tartrate on the EDQM register, including HETERO DRUGS LIMITED Hyderabad (IN), FLEMING LABORATORIES LIMITED Hyderabad (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN), MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village (IN) and Interquim, S.A. Sant Cugat Del Vallès (ES) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Tolterodine Tartrate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Tolterodine Tartrate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.